Mary Lynn McPherson
speaker
498 appearances
2 recordings
1 series
first heard Oct 2018
last heard Dec 2021
Mary Lynn McPherson’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsNo recordings in the last 12 months.Older appearances are listed below; set an alert to hear about the next one.
Appearances
Certainly you can push it to two, two and a half, but you risk blowing your sight, but
Boy, any hospice nurse in the country will tell you if somebody blows their access in the middle of the night, sometimes you can talk a family member through reestablishing sub Q access and not even have to make a visit, but certainly not with IV.
Pretty much all of them.
Yes.
So uh it's it's we have pretty wide acceptance there.
I worked with a resident to come up with a a guide for parental administration of the top fifty drugs we use in hospice and palliative care.
So
I'll be happy to share that with you.
Yeah.
Uh I think it'll be interesting to see what happens with the Kappa agonists.
So stay tuned on that.
I mean I've not heard of anything else that's like, you know.
hold the presses, but we'll we'll see with the Kappa Agonists how that pans out.
You know, I think the United States is is in some ways behind the rest of the world in using buprenorphine as an analgesic.
Certainly we have butrans and we have Belbuca.
They're both branded products.
They're fairly expensive.
And there's a pretty significant level of discomfort among practitioners with buprenorphine.
It is a partial agonist, but it's got a higher affinity for the immuoreceptor than the traditional opiates such as morphine and
and a hydrocodone and oxycodone, for example.
Showing 361–380 of 498 · page 19 of 25
← Previous
Next →